Prostate cancer

You have access
Enhancing Estimation Accuracy of Prostate Cancer VMAT Planning: A Knowledge-based Approach Using Multiple Collimator Angles
TATSUYA KAMIMA, YOSHIHIRO UEDA, JUN-ICHI FUKUNAGA, YUMIKO SHIMIZU, YASUO YOSHIOKA and HAJIME MONZEN

Anticancer Research December 2024, 44 (12) 5303-5312; DOI: https://doi.org/10.21873/anticanres.17358
Open Access
TMPRSS2:ERG Gene Fusion Might Predict Resistance to PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer
TIM SVENSTRUP POULSEN, ANDERS NYGAARD LØRUP, PER KONGSTED, RIKKE LØVENDAHL EEFSEN, MARTIN HØJGAARD and ESTRID VILMA HØGDALL

Anticancer Research October 2024, 44 (10) 4203-4211; DOI: https://doi.org/10.21873/anticanres.17250
Open Access
Changes in Bladder Volume During Radiotherapy for Prostate Cancer
DIRK RADES, FLORIAN CREMERS, CHRISTIAN ZIEMANN, LAURA SPLETTSTÖSSER, CARLOS A. NARVAEZ-WOLF, AHMED AL-SALOOL, MICHAEL VON STADEN, JAN-DIRK KÜTER, STEFAN JANSSEN and CARMEN TIMKE

Anticancer Research October 2024, 44 (10) 4457-4463; DOI: https://doi.org/10.21873/anticanres.17275
Open Access
[¹¹C]Methionine PET vs. [¹⁸F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
MOTOKAZU SATO, TOSHIHIKO SATO, CHIHIRO HOZUMI, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN

Anticancer Research September 2024, 44 (9) 3891-3898; DOI: https://doi.org/10.21873/anticanres.17216
You have access
Prescription Medications and Overall Survival in Metastatic Hormone Sensitive Prostate Cancer
CARLEY PICKETT, KRISHNY KARUNANANDAA, KAITLIN STACKABLE, DANIEL B. EATON, STEVEN TOHMASI, DEEPIKA GOPUKUMAR, VARUN PURI and MARTIN W. SCHOEN

Anticancer Research August 2024, 44 (8) 3443-3449; DOI: https://doi.org/10.21873/anticanres.17164
You have access
hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3–Erk1/2 Signaling Pathway
SEHYEON HAN, SOYOUNG JANG, SEOUNG-WOO LEE, HEE-YEON KIM, WANSOO KIM, HYEON-GYEOM KIM, JIN-KYU PARK, JEE EUN HAN, ZAE YOUNG RYOO, ETHAN SEAH, CHOONOK KIM, JIYEON LEE, SONG PARK and SEONG-KYOON CHOI

Anticancer Research July 2024, 44 (7) 2847-2859; DOI: https://doi.org/10.21873/anticanres.17097
Open Access
Photoimmunotherapy of Prostate Cancer With Antibody and Fab Fragments Targeting the Prostate Specific Membrane Antigen
SARAH WAIBEL, NELE GRAF, JONAS STORZ, SUSANNE SCHULTZE-SEEMANN, SUSAN LAUW, CHRISTIAN GRATZKE, REINHARD BRÜCKNER, PHILIPP WOLF and ISIS WOLF

Anticancer Research June 2024, 44 (6) 2343-2348; DOI: https://doi.org/10.21873/anticanres.17041
You have access
Hispidin Increases Cell Apoptosis and Ferroptosis in Prostate Cancer Cells Through Phosphatidylinositol-3-Kinase and Mitogen-activated Protein Kinase Signaling Pathway
YAN-JIE WANG, YING-YING HAO, DONG HUN LEE, XIAO-YU GUO, HU-NAN SUN and TAEHO KWON

Anticancer Research June 2024, 44 (6) 2533-2544; DOI: https://doi.org/10.21873/anticanres.17059
You have access
MAOA Inhibitor Plus Docetaxel in Patients Receiving and Progressing on Docetaxel Therapy
TAYLOR AMERY, SHAADI TABATABAEI, MAYA SONPATKI, EVAN Y. YU and TOMASZ M. BEER

Anticancer Research May 2024, 44 (5) 2247-2248; DOI: https://doi.org/10.21873/anticanres.17033
Open Access
Breath of Danger: Unveiling PM2.5’s Stealthy Impact on Cancer Risks
KEFAH MOKBEL

Anticancer Research April 2024, 44 (4) 1365-1368; DOI: https://doi.org/10.21873/anticanres.16932

Main menu

User menu

Search

Prostate cancer

Pages